OTC · SSUR
StatSure Diagnostic Systems, Inc.
Healthcare · Medical - Devices
$0.00
Down-$0.05 (-99.60%)
Updated Sep 13, 2026, 11:07 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 107.06K
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- — – —
- Volume
- 1
- Avg. volume
- 2
Price performance
SSUR price history
1M range · 0 trading sessions · Daily adjusted prices
SSUR does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest SSUR news
The latest Smart Investors Daily articles mentioning SSUR.
Stock researchCompany · Overview
SSUR research
Overview
Company profile and research snapshot.
Company profile
StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2. It also provides medical specimen collection devices. The company was founded in 1986 and is based in Brooklyn, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
